Life saving drugs’ uncertain future

The Federal Government has sacked more than 20 medical experts from five Disease Advisory Committees (DACs) this month, following a review of its Life Savings Drugs Program (LSDP).

As reported by News Limited, the expert committees has been disbanded as the government reviews the program, examining issues such as access, cost-benefit and the future administration of the program.